慢性阻塞性肺病应用利舒康胶囊治疗的临床疗效分析  

Analysis of the Clinical Effect of Lishukang Capsule on Chronic Obstructive Pulmonary Disease

作　　者：邢国燕[1] 赵树波[1] XING Guo-yan;ZHAO Shu-bo(Tonghua Central Hospital,Tonghua,Jilin 134000)

机构地区：[1]吉林省通化市中心医院

出　　处：《智慧健康》2019年第35期183-184,共2页Smart Healthcare

摘　　要：目的探究应用利舒康胶囊对慢性阻塞性肺疾病的临床治疗效果分析。方法选择我院2018年5月至2019年5月收治的慢性阻塞性肺疾病患者68例,以不同的治疗方法为分组依据,将其随机分为观察组(n=34)与对照组(n=34),对照组患者行无创正压通气治疗,观察组患者在此基础上联合利舒康胶囊进行治疗。对比两组患者的血气指标改善情况及治疗有效率。结果观察组患者SaO2、PaCO2、PaO2三项相关指标均较对照组更优(P<0.05),差异具有统计学意义。另外,观察组患者的治疗总有效率为91.18%,显著高于对照组的79.41%(P<0.05),差异显著。结论对慢性阻塞性肺疾病患者采取利舒康胶囊治疗临床疗效显著,能够有效改善患者的血气指标,使治疗效果显著提升,临床应用价值高,值得推广。Objective To explore the clinical therapeutic effect of Lishukang Capsule on chronic obstructive pulmonary disease.Methods Sixty-eight patients with chronic obstructive pulmonary disease admitted to our hospital from May 2018 to May 2019 were randomly divided into observation group(n=34)and control group(n=34)according to different treatment methods.Patients in the control group were treated with noninvasive positive pressure ventilation,and patients in the observation group were treated with Lisukang Capsule on this basis.The improvement of blood gas index and the effective rate of treatment were compared between the two groups.Results The three related indexes of SaO2,PaCO2 and PaO2 in the observation group were better than those in the control group(P<0.05).In addition,the total effective rate of the observation group was 91.18%,which was significantly higher than that of the control group(79.41%)(P<0.05).Conclusion The clinical effect of Lishukang Capsule on patients with chronic obstructive pulmonary disease is significant,which can effectively improve the blood gas index of patients,significantly improve the treatment effect,and has high clinical application value,which is worth promoting.

关 键 词：利舒康胶囊 慢性阻塞性肺疾病 通气治疗 临床疗效 

分 类 号：R563.9[医药卫生—呼吸系统]